BCLC STAGE C HEPATOCELLULAR CARCINOMA
Clinical trials for BCLC STAGE C HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BCLC STAGE C HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for BCLC STAGE C HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple therapy shows promise for tough liver cancer cases
Disease control CompletedThis study tested whether adding a liver-directed chemotherapy infusion (HAIC) to the usual combination of lenvatinib and a PD-1 inhibitor improves outcomes for people with advanced liver cancer that has spread into the portal vein. 244 patients with high tumor burden were includ…
Matched conditions: BCLC STAGE C HEPATOCELLULAR CARCINOMA
Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated May 26, 2026 05:14 UTC
-
New drug combo shows promise for tough liver cancers
Disease control CompletedThis study tested a combination of two drugs, futibatinib and pembrolizumab, in 14 adults with advanced or metastatic liver cancer that had not responded to prior treatment. The goal was to see if the combination could stop or slow cancer growth. Participants received both drugs,…
Matched conditions: BCLC STAGE C HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
AI scans may pick better liver cancer therapy
Knowledge-focused CompletedThis study looked at medical scans from 3,000 liver cancer patients to see if artificial intelligence could tell which treatment—TACE or HAIC—works best for each person. Researchers used a computer model to group patients by tumor appearance and then compared survival and tumor s…
Matched conditions: BCLC STAGE C HEPATOCELLULAR CARCINOMA
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated May 26, 2026 04:34 UTC